112 related articles for article (PubMed ID: 29209772)
1. Influence of the ABCB1 polymorphisms on the response to Taxane-containing chemotherapy: a systematic review and meta-analysis.
Jiang Q; Xu M; Liu Y; Chen Y; Feng J; Wang X; Liang S; Li D; Yang X
Cancer Chemother Pharmacol; 2018 Feb; 81(2):315-323. PubMed ID: 29209772
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Two Polymorphisms, rs1045642 and rs1128503, in ABCB1 Following Taxane-based Chemotherapy: A Meta-Analysis.
Chen Q; Lin W; Yang J; Lin M; Lin X; Weng Y; Chen Y
Asian Pac J Cancer Prev; 2021 Jan; 22(1):3-10. PubMed ID: 33507672
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
Sun Z; Yang X; Du F; Shi Y; Sun J; Jia J; Liu C; Xiao Y; Yu J; Zhang X; Yang Y
J Gene Med; 2022 Jul; 24(7):e3434. PubMed ID: 35662334
[TBL] [Abstract][Full Text] [Related]
4. ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.
Zhong J; Guo Z; Fan L; Zhao X; Zhao B; Cao Z; Cheng L; Shi Y; Li X; Zhang Y; An T; Wu M; Wang Y; Zhuo M; Li J; Yang X; Chen H; Jia B; Zhao J
Thorac Cancer; 2019 Nov; 10(11):2088-2095. PubMed ID: 31571407
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Assessment of the Association between ABC Polymorphisms and Osteosarcoma Response: a Meta-analysis.
Chen X; Jiang M; Zhao RK; Gu GH
Asian Pac J Cancer Prev; 2015; 16(11):4659-64. PubMed ID: 26107220
[TBL] [Abstract][Full Text] [Related]
6. Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis.
Yan M; Fan X; Si H; Wang X; Wang Z; Wang Z; Lv X; Yin H; Jia Y; Jiang L; Xia Y; Liu Y
Cancer Chemother Pharmacol; 2022 Feb; 89(2):173-181. PubMed ID: 34988655
[TBL] [Abstract][Full Text] [Related]
7. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in Indonesia.
Barliana MI; Kusuma ASW; Insani WN; Alfian SD; Diantini A; Mutakin M; Rostinawati T; Herlambang H; Puspitasari IM; Suwantika AA; Abdulah R
BMC Res Notes; 2021 Jul; 14(1):295. PubMed ID: 34332626
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes.
Angelini S; Botticelli A; Onesti CE; Giusti R; Sini V; Durante V; Strigari L; Gentile G; Cerbelli B; Pellegrini P; Sgroi V; Occhipinti M; DI Pietro FR; Rossi A; Simmaco M; Mazzuca F; Marchetti P
Anticancer Res; 2017 May; 37(5):2633-2639. PubMed ID: 28476838
[TBL] [Abstract][Full Text] [Related]
11. The role of ABCB1 gene polymorphisms in steroid-resistant nephrotic syndrome: Evidence from a meta-analysis of steroid-receiving patients.
Aziz MA; Islam MS
J Gene Med; 2022 Jul; 24(7):e3436. PubMed ID: 35697639
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population.
Yan RJ; Lou TT; Wu YF; Chen WS
Medicine (Baltimore); 2017 Feb; 96(5):e5929. PubMed ID: 28151874
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells.
Sumarpo A; Ito K; Saiki Y; Ishizawa K; Wang R; Chen N; Sunamura M; Horii A
Biochem Biophys Res Commun; 2020 Jun; 526(3):586-591. PubMed ID: 32247608
[TBL] [Abstract][Full Text] [Related]
14. Brain/blood ratios of methadone and ABCB1 polymorphisms in methadone-related deaths.
Iwersen-Bergmann S; Plattner S; Hischke S; Müller A; Andresen-Streichert H; Jungen H; Erb R; Beer-Sandner B
Int J Legal Med; 2021 Mar; 135(2):473-482. PubMed ID: 33454797
[TBL] [Abstract][Full Text] [Related]
15. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy.
Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K
Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132
[TBL] [Abstract][Full Text] [Related]
16. Taxane containing regimens for metastatic breast cancer.
Ghersi D; Wilcken N; Simes J; Donoghue E
Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
[TBL] [Abstract][Full Text] [Related]
17. ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.
Kim JW; Kim JH; Im SA; Kim YJ; Han HS; Kim JS; Han SW; Jeon YK; Oh DY; Han W; Kim TY; Park IA; Noh DY; Bang YJ
Oncology; 2012; 83(4):218-27. PubMed ID: 22906996
[TBL] [Abstract][Full Text] [Related]
18. Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity.
Guilhaumou R; Solas C; Bourgarel-Rey V; Quaranta S; Rome A; Simon N; Lacarelle B; Andre N
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1633-8. PubMed ID: 21968951
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of
Chang Q; He ZL; Peng YC; Duan SG; Dai YX; Zhao XH
J Int Med Res; 2019 Jul; 47(7):2800-2809. PubMed ID: 31234681
[TBL] [Abstract][Full Text] [Related]
20. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
